# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-23T11:38:18.378774

---

**Idea Fidelity**

The paper adheres closely to the original idea manifest. It uses California SB 328 as a natural experiment, FARS data (2015–2023), and a synthetic DiD/triple-difference framework to study teen morning fatalities. The manifest’s emphasis on permutation inference and the fragility of single-treated-unit TWFE estimation is reflected throughout the paper. The main elements—teen versus adult contrast, morning versus evening hours, and placebo tests—are present. The only omission is a more explicit use of the Education Data API or within-state compliance variation; the paper mentions compliance heterogeneity qualitatively but does not exploit it, whereas the manifest suggested it as a potential identification nuance. However, this omission does not materially alter the core identification strategy.

---

**Summary**

The paper evaluates whether California’s SB 328 mandate, which delayed public high school start times statewide effective July 2022, reduced teen (ages 15–19) motor vehicle fatalities during morning hours. Using person-level FARS data, the author contrasts California’s morning teen fatality rates with a synthetic control and with several triple-difference specifications, finding a positive TWFE estimate but no statistically significant effect under permutation inference. The null result is interpreted as evidence that the presumed safety dividend from later starts is not detectable in the available data, and the paper emphasizes the importance of appropriate inference in single-treated-unit designs.

---

**Essential Points**

1. **Credibility of the Counterfactual**: The main identifying assumption is that, absent SB 328, California’s teen morning fatality trajectory would have followed other states’ trends. Yet the event study shows volatile and occasionally significant pre-trends, and there is little discussion of why California’s trajectory might differ systematically (e.g., differential changes in infrastructure, enforcement, or teen driving exposure post-COVID). The synthetic DiD partially addresses fit, but the paper lacks diagnostics (e.g., pre-treatment fit metrics, placebo gap plots) demonstrating that the synthetic control closely tracks California. Strengthening this piece—by showing, for example, pre-period root mean squared prediction errors, or by conditioning on states with similar pre-2022 running trends—would bolster the credibility of the counterfactual. Without that, the null finding may simply reflect mis-specified counterfactuals.

2. **Interpretation of the Poisson/Triple-Difference Coefficients**: Columns 3 and 4 of Table 2 report large, statistically significant coefficients (0.10 on the triple-difference and a 34% Poisson increase), yet the text dismisses them as spurious due to permutation inference. It remains unclear whether these estimates capture real substantive changes (e.g., teens shifting into heavier traffic) or are driven by statistical noise. The author should reconcile these large point estimates with the null permutation inference more explicitly—e.g., by showing the distribution of placebo triple-difference estimates and explaining how the point estimate compares—or by presenting confidence intervals that reflect permutation-based uncertainty. Right now, readers are left wondering whether the null is a statistical artifact or if it simply reflects the impossibility of estimating precise point effects with sparse counts.

3. **Heterogeneity and Compliance**: The policy was implemented state-wide but with staggered compliance (e.g., rural exemptions, districts with labor agreements delaying changes, and some schools already compliant). The empirical strategy treats California as uniformly treated. This likely attenuates the estimated effect, but it also raises concerns about whether the treated population aligns with the causal contrast of interest. The paper should either (a) exploit within-California variation (e.g., compare districts that were late vs. early adopters using variation in compliance timing), or (b) estimate an intent-to-treat (ITT) effect while showing that the post-period population indeed experienced a substantial shift in start times (e.g., using Education Data API or other administrative sources). Presenting evidence on compliance/incentive dose would help interpret the effect size and the absence of a detectable safety dividend.

If these issues cannot be resolved, the paper would not be acceptable for publication in its current form; specifically, if the counterfactual remains unconvincing and the diffusion of treatment is unverifiable, the paper should be rejected.

---

**Suggestions**

1. **Expand the Synthetic Control Diagnostics**: Provide figures showing the pre-treatment fit of the synthetic control (actual California rate versus synthetic) as well as post-treatment gaps, along with measures like RMSPEs and placebo gaps for other states. This would help readers gauge how reliable the synthetic DiD estimates are and whether California’s pre-period volatility is unique or shared by other states. If the pre-treatment fit is poor, consider reweighting control states or adjusting the pre-period length/hours to achieve better balance.

2. **Report Permutation Inference for All Key Specifications**: Permutation $p$-values are currently reported for the TWFE estimate but not for the triple-difference or Poisson specifications. Since the paper relies heavily on the permutation exercise to overturn conventional inference, extend this procedure to the other specifications (especially the triple-difference and Poisson models). Display the full distribution of placebo estimates (e.g., via a histogram or density plot) with California’s point estimate marked. Permutation-based confidence intervals would also be useful.

3. **Clarify the Statistical Interpretation of the Hour-of-Day Table**: The hour-of-day distribution table is suggestive but inconclusive. Consider formalizing this section by conducting a shift-share test (e.g., a multinomial logit or Kolmogorov-Smirnov test with bootstrapped confidence intervals) to test whether the distribution changed meaningfully in magnitude, not just share. Alternatively, rescale the counts per million teen-hours driven (if exposure data are available) to better interpret shifts.

4. **Address Power Considerations More Directly**: The paper notes sparse counts but does not quantify the minimum detectable effect given the data. Adding a section or appendix that simulates the power to detect a (say) 10% reduction in fatality rates given the observed variance and sample size would help readers understand whether the null result is due to insufficient signal or because the effect is truly zero. This would also contextualize the observed permutation $p$-value.

5. **Explore Additional Outcomes or Aggregations**: Since the event is recent and the outcome rare, consider complementary outcomes that may be more sensitive, such as non-fatal crash counts (if available), hospitalization data, or ambulance response logs. Even if these data are unavailable, aggregating to quarterly or annual bins could stabilize the counts and permit inference. At minimum, explain why such alternatives were not pursued and what the magnitude of detection would be under those specifications.

6. **Explain the Triple-Difference Specification in Greater Detail**: The triple-difference plays a central role, but its implementation is terse. Explicitly write out the constructed interaction terms, clarifying what variation is identified and how the included fixed effects absorb confounders. Also, explain why the triple-difference coefficient should be interpreted as the differential teen-morning change in California relative to other groups, and discuss whether any remaining confounders (e.g., teen evening behavioral changes) could still bias this estimate.

7. **Be Explicit About Policy Implications Given a Null**: The discussion frames the null as challenging the “save lives” claim, but also acknowledges alternative explanations (e.g., congestion effects). Enhance this section by quantifying the implied bounds: e.g., “Given the 34% standard TWFE coefficient but permutation $p=0.59$, we cannot rule out an effect as large as X% in either direction.” This would prevent readers from interpreting the null as definitive evidence that SB 328 failed, while still emphasizing the policy relevance of a well-identified (if not precisely estimated) effect.

8. **Document the Data Construction Pipeline**: The paper is transparent about data sources but does not detail how the hourly bins are constructed from FARS (e.g., how missing hours are handled, timezone issues, imputation of crash hours). Provide a short appendix or footnote describing the data cleaning steps, any exclusions (e.g., off-highway crashes), and how population denominators were interpolated for mid-year months. This will enhance reproducibility and help others evaluate the validity of the rate calculations.

9. **Consider Alternative Permutation Schemes**: The current permutation assigns placebo treatment to each state equally. Given that SB 328 is a large-state policy and the treated unit is California, alternative permutations (e.g., weighting by population or limiting the pool to states with similar pre-trends) could be informative. At least discuss why the uniform permutation is appropriate and whether the result is robust to other plausible schemes.

10. **Tighten Language Around Methodological Contribution**: The paper positions itself partly as a methodological caution about clustered SEs in single-treated-unit settings. While this is valid, ensure the discussion distinguishes between what is novel about the application (school start time policy) versus what is standard methodological practice (permutation inference). Consider citing and comparing to other recent work that also uses permutation inference or randomization inference in similar policy contexts.

By addressing these suggestions, the paper would offer a clearer, more credible assessment of SB 328’s impact and a stronger methodological lesson for empirical researchers working with rare outcomes and single treated units.
